Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Zhejiang Cancer Hospital"
Count: 290
Selected: 0
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT05794841Multi-omics Study of Tongue Coating in Malignant Tumors of Digestive Tract
NCT05651802PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC Patients
NCT02992067CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer
NCT06055816Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma
NCT05228496A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Sitravatinib as Maintenance Therapy for ES-SCLC
NCT06048289Prospective Observational Study to Predict the Response of Biliary Tract Tumors to Immunotherapy
NCT04119674Pilot Study of Anlotinib With STUPP Regimen for Patients With Newly Diagnosed Glioblastoma
NCT06046963Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites
NCT060063383D Printed Models for Liver Surgery
NCT05992597ZR2 Sequential Immunochemotherapy for Newly Treated MCL
NCT04790409Sintilimab Combined With Anlotinib in Advanced NSCLC With EGFR Uncommon Mutations
NCT06031597Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction Immunochemotherapy
NCT05920863Lenvatinib Combined With Tislelizumab and TACE Applied as Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma With High-risk Recurrence Factors
NCT05557578GOT Applied as Neoadjuvant Regimen for Patients of Resectable ICC With High-risk Factors of Recurrence
NCT05212064HFNC and Hypoxia During Percutaneous Radiofrequency Ablation Under Conscious Sedation: A Randomized Clinical Trial
NCT05991947Preliminary Experimental Study on Key Technologies for Early Screening of Gastric Cancer
NCT05985577Mechanism of Gastric Signet Ring Cell Carcinoma Based on Microproteomics
NCT05290090ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL
NCT05974085XPO-1 in Combination With RCHOP for DH/TH Lymphoma
NCT05971199Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular Carcinoma
NCT04808752Almonertinib as First-line Treatment in Patients With EGFR Mutations Positive in Advanced NSCLC With Brain Metastases
NCT05963087Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
NCT05958849Advanced Pancreatic Cancer
NCT05928312Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal Cancer
NCT02923128Whether Dexmedetomidine Can Improve the Prognosis of Elderly Patients With Postoperative Cognitive Dysfunction
NCT05911425Combined Treatment of Treated Bile Duct Cancer
NCT05903456Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma
NCT05896059A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLC
NCT05856383Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABC
NCT05126160Immune Score Based Radiomics in Nasopharyngeal Carcinoma
NCT05813626Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT05183958A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
NCT05705583A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell Carcinoma
NCT04162691Single Cell Sequencing Analysis of Thymoma
NCT05669807Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer
NCT05669092A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI Status
NCT05007587Lenvatinib Plus HAIC of Modified FOLFOX Regime vs Lenvatinib Plus HAIC of ROX Regime in Patients With Advanced HCC
NCT05652192SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
NCT05617469DLCS for Predicting Neoadjuvant Chemotherapy Response
NCT05385809A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric Cancer
NCT05596071Whether Opioids Are Factor That Induced POD?
NCT05468671Clinical Application Value of Remazolam Combined With Sugammadex Sodium in Anesthesia for Endotracheal Surgery Under Bronchoscopy
NCT05564897Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer
NCT05559775A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard Therapy
NCT05550090Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC
NCT05544149TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
NCT05489926A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure
NCT05528367Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma
NCT05514275Radiotherapy Combined With Endostatin and Capecitabine for NPC